AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 20- 52-wk high
- $96.29
- 52-wk low
- $72.30
- Prev close
- $92.28
- Mkt cap
- $52.44B
- P/E
- 54.1x
- Fwd P/E
- 30.3x
Smart money
Earnings
Earnings came in 6.8% above what analysts expected.
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.55B | $1.57B | $1.65B | $1.74B |
| Cost of what it sold | $345.2M | $340.6M | $359.3M | $390.6M |
| Gross profit | $1.21B | $1.23B | $1.29B | $1.35B |
| What it spent | ||||
| Research and development | $280.7M | $267.7M | $263.3M | $278.9M |
| Sales and admin | $514.6M | $602.9M | $522.2M | $561.2M |
| Other operating costs | -$10.8M | -$11.9M | -$10.9M | -$9.2M |
| Total operating expenses | $784.5M | $858.7M | $774.6M | $830.9M |
| What was left | ||||
| Operating profit | $425.1M | $370.3M | $514.7M | $519.5M |
| Profit before tax | $348.4M | $90.4M | $459.0M | $519.8M |
| Tax | $56.1M | $26.2M | $78.3M | $278.4M |
| Net profit | $291.1M | $91.2M | $380.7M | $241.9M |
| EBITDA | $387.6M | $133.1M | $499.9M | $519.5M |
Technicals
Price structure
No data yet
Technicals sync when verified market data is available. No sample data is shown.
News
What the news says
37 articles · 7 days
Coverage is bullish
Tone of tracked coverage
Edwards Lifesciences stock holds steady as analysts see upside
Leans bullishAug 18OneDigital Investment Advisors LLC Takes $1.27 Million Position in Edwards Lifesciences Corporation $EW
NeutralAug 18Oppenheimer Asset Management Inc. Purchases Shares of 22,090 Edwards Lifesciences Corporation $EW
Bullish
